Error: Could not add to watchlist. X
+ Watchlist

Biotie Therapies OYJ

BTH1V:FH
Acquired
BTH1V:FH was acquired by ACOR:US
EUR
Volume
0
52Wk Range
0.28 - 0.32
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
52Wk Range
0.28 - 0.32
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-0.05
Market Cap (EUR)
-
Shares Outstanding (m)
983.520
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.08%
% Price Change
+0.07%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Biotie Therapies Oyj operates as a biopharmaceutical company. The Company focuses on developing therapeutics for central nervous system disorders. Biotie Therapies serves customers worldwide.
Address
Joukahaisenkatu 6
Turku, FI-20520
Finland
Phone
358-2-274-8900
Show More